MedPath

Alalevonadifloxacin mesylate

Generic Name
Alalevonadifloxacin mesylate

Study to Determine and Compare Plasma and Intrapulmonary Pharmacokinetics of WCK 2349 in Healthy Adult Human Subjects

Phase 1
Completed
Conditions
Intrapulmonary Pharmacokinetics of WCK 2349
Interventions
First Posted Date
2014-10-01
Last Posted Date
2015-10-29
Lead Sponsor
Wockhardt
Target Recruit Count
30
Registration Number
NCT02253342
Locations
🇺🇸

Pulmonary Associates, 1112 E. McDowell Rd., Phoenix, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath